Your browser doesn't support javascript.
loading
Efficacy and safety of standard of care with/without bevacizumab for platinum-resistant ovarian/fallopian tube/peritoneal cancer previously treated with bevacizumab: The Japanese Gynecologic Oncology Group study JGOG3023.
Shoji, Tadahiro; Enomoto, Takayuki; Abe, Masakazu; Okamoto, Aikou; Nagasawa, Takayuki; Oishi, Tetsuro; Nagase, Satoru; Mori, Masahiko; Inokuchi, Yuki; Kamiura, Shoji; Komiyama, Shinichi; Takeshima, Nobuhiro; Sugiyama, Toru.
Afiliação
  • Shoji T; Department of Obstetrics and Gynecology, Iwate Medical University School of Medicine, Iwate, Japan.
  • Enomoto T; Department of Obstetrics and Gynecology, Niigata University School of Medicine, Niigata, Japan.
  • Abe M; Department of Gynecology, Shizuoka Cancer Center, Shizuoka, Japan.
  • Okamoto A; Department of Obstetrics and Gynecology, The Jikei University School of Medicine, Tokyo, Japan.
  • Nagasawa T; Department of Obstetrics and Gynecology, Iwate Medical University School of Medicine, Iwate, Japan.
  • Oishi T; Department of Obstetrics and Gynecology, Tottori University School of Medicine, Tottori, Japan.
  • Nagase S; Department of Obstetrics and Gynecology, Faculty of Medicine, Yamagata University, Yamagata, Japan.
  • Mori M; Department of Gynecology, Aichi Cancer Center Hospital, Aichi, Japan.
  • Inokuchi Y; Department of Biostatistics, Kitasato Academic Research Organization, Kitasato University, Tokyo, Japan.
  • Kamiura S; Department of Gynecologic Oncology, Osaka International Cancer Institute, Osaka, Japan.
  • Komiyama S; Department of Obstetrics and Gynecology, Faculty of Medicine, Toho University, Tokyo, Japan.
  • Takeshima N; Department of Gynecology, Cancer Institute Hospital, Tokyo, Japan.
  • Sugiyama T; Department of Obstetrics and Gynecology, St. Mary's Hospital, Fukuoka, Japan.
Cancer Sci ; 113(1): 240-250, 2022 Jan.
Article em En | MEDLINE | ID: mdl-34716979

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias Peritoneais / Resistencia a Medicamentos Antineoplásicos / Neoplasias das Tubas Uterinas / Bevacizumab / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias Peritoneais / Resistencia a Medicamentos Antineoplásicos / Neoplasias das Tubas Uterinas / Bevacizumab / Antineoplásicos Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Middle aged Idioma: En Ano de publicação: 2022 Tipo de documento: Article